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INADEQUACY OF N-3 POLYUNSATURATED FATTY ACID DIETARY 
INTAKES IN THE GENERAL FRENCH POPULATION OF ELDERLY 
(65 TO 79 YEARS OLD): THE INCA 2 SURVEY  
B. Buaud1, J. Tressou2, P. Guesnet3, N. Simon4, S. Pasteau5
Abstract: Objectives: The aim of this study was to explore polyunsaturated fatty acid (PUFA) intakes in the French elderly 
population (65 to 79 years old). Design: The study used data on French food consumption issued from 348 elderly of the cross-
sectional national French INCA 2 dietary survey performed in 2006 and 2007, combined with the nutritional content of food 
consumed updated in 2013 by the French Information Center on Food Quality. Results: It was observed for the French elderly 
population an adequate total fat daily intake and a linoleic acid (LA) daily intake close or superior to the recommended dietary 
intake (RDI) by the French authorities (from 4.1 to 4.4% of the total energy intake excluding alcohol (EIEA) vs 4% EIEA). By 
contrast, the French elderly have, regardless of age and gender, a low mean dietary alpha-linolenic acid (ALA) intake equal half 
of the RDI (0.5% EIEA vs 1% EIEA), and a mean dietary docosahexaenoic acid (DHA) intake close to two-thirds of the RDI (i.e. 
from 154 to 167 mg/d vs 250 mg/d). These translated into a LA/ALA ratio between 9.5 and 9.9, twice as high as the recommended 
threshold inferior to 5, and a mean dietary eicosapentaenoic acid (EPA) plus DHA intake (from 267 to 293 mg/d) slightly more 
than half of the RDI (500 mg/d). Conclusion: This study supports the need to promote higher intakes of n-3 PUFAs, as well as the 
setting of specific intake recommendations for these fatty acids for the French elderly population.
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Introduction  
Polyunsaturated fatty acids (PUFAs) include n-6 and 
n-3 fatty acids. Linoleic acid (18:2n-6, LA), and alpha-
linolenic acid (18:3n-3, ALA), the precursors of n-6 and 
n-3 series respectively, are both essential fatty acids that 
cannot be synthesized by humans and must be supplied 
with the diet. Beneficial effects of LA have been reported 
on blood lipid profile, and its association with a lower 
risk of coronary heart disease (CHD) events and reduced 
risk of type 2 diabetes (1). Although clinical benefits 
have not been observed across all studies, several 
experimental and prospective observational studies 
support that ALA consumption reduces the incidence 
of CHD (2). N-3 long-chain PUFAs eicosapentaenoic 
(20:5n-3, EPA) and docosahexaenoic acids (22:6n-3, 
DHA), that are essentially derived from marine sources, 
and to a lesser extent issued from the conversion of 
ALA which occurs at a very low rate in humans, have 
demonstrated physiological benefits on blood pressure, 
heart rate, triglycerides, and likely inflammation, 
endothelial function, and cardiac diastolic function [3]. 
In France, where life expectancy is among the highest in 
the world, the older population has specific nutritional 
requirements in order to avoid malnutrition and also 
more subtle deficiencies due to the current imbalanced 
Western diets. To this end, there is a growing interest 
in the putative protective effects of n-3 PUFAs against 
cardiovascular disease, cancer and neuro-psychiatric 
disorders, whose incidence sharply increases with age 
(4). But although n-3 PUFAs seem essential as enhancers 
to be consumed for the promotion of healthy aging, no 
specific dietary recommendations are formulated for 
elderly in France as in many European countries. Several 
international and national organizations have indeed 
proposed recommended dietary intakes (RDIs) for PUFAs 
for specific population groups (such as pregnant and 
lactating women, infants, children and adolescents) and 
for the general adult population, while specifying that the 
RDI of adults could also be valid for the elderly (5). As 
reported by a recent review, the intake of PUFAs, notably 
n-3 PUFAs, is suboptimal in many European countries 
(5), like it has been showed in France by the data from 
the cross-sectional national French INCA 2 dietary survey 
(2006-2007) (6). Evaluated against the French Agency for 
Food, Environmental and Occupational Health & Safety 
(ANSES) recommendations (7), only 2.3, 7.8, and 14.6% of 
the French adult population met RDIs for ALA, EPA, and 
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DHA respectively. Since very few studies have focused 
on PUFA intake of French elderly, the objective of our 
study was to explore PUFA intakes in French elderly 
(≥ 65 and ≤ 79 years old, both genders) using the data 
on French food consumption issued from the French 
National Survey INCA 2 performed in 2006 and 2007, 
combined with the nutritional content of food consumed 
updated in 2013 by the French Information Center on 
Food Quality (8).
Material and methods
Following the same methodology as in Tressou et al. 
(6), INCA 2 data was combined to the ANSES Ciqual 
2013 composition database (https://pro.anses.fr/
TableCIQUAL/) to compute intakes of all fatty acids for 
the 348 adults aged from 65 to 79 years old. The group 
was further divided into 3 subgroups 65-69, 70-74, and 
75-79 years old with sizes 150, 114, 84, respectively, and 
a mean female ratio of 56.6% (60% for 65-69 y, 55.3% 
for 70-74 y, and 52.4% for 75-79 y). This is sufficient 
to compute statistics by age group and by gender. As 
in Tressou et al. (6) and as recommended by ANSES, 
results are balanced using the weights provided in the 
INCA 2 database to get results that are representative 
of the French population. Calculations are performed 
with survey package of the R software. For each age 
group, daily intakes are expressed in grams per day 
(g/d) and as a percentage of the energy intake excluding 
alcohol (EIEA) for LA and ALA, and in milligrams 
per day (mg/d) for EPA and DHA. These intakes are 
compared to the current ANSES recommendations, and 
the percentages of elderly people meeting these RDIs are 
calculated. Moreover, the percentages of elderly people 
ingesting the adequate levels of LA and ALA required for 
a healthy entire organism functioning are also calculated. 
Similar to European Food Safety Authority (EFSA) 
and Food and Agriculture Organisation (FAO) / 
World Health Organisation (WHO), no specific 
dietary recommendations were formulated for 
elderly in France as in many European countries (5). 
Japan is the worldwide only country to define specific 
recommendations for total n-3 PUFAs for elderly, 
stratified by age (50-69 y, and over 70 y) and gender (9). 
Although France discussed the specific dietary needs of 
the elderly at the early 2000s, the current French RDIs for 
lipid and PUFA intake in elderly are similar to those for 
the adult population, as no specific needs for any of the 
PUFAs were deemed evident for this age group according 
to the updated ANSES recommendations (10).
The current French RDIs for lipid and PUFA intake 
in adult (> 18 years old) differ in terms of disease 
prevention towards the metabolic syndrome, diabetes 
and obesity, cardiovascular diseases, breast and colon 
cancers, neurological diseases and age-related macular 
degeneration. For the healthy adult population, the mean 
French RDIs for total lipid fat intake are included between 
35 and 40% EIEA. The mean RDIs for LA and ALA are 4% 
EIEA and 1% EIEA respectively, with a recommended 
LA/ALA ratio lower than 5. The mean RDIs for DHA and 
EPA+DHA are 250 mg/d and 500 mg/d, respectively. 
Based on scientific data which generally deal with the 
effects of EPA+DHA, a 250 mg/d RDI-like figure is 
derived from the DHA and EPA+DHA RDIs to evaluate 
the adequacy of EPA intake. ANSES has also defined 
adequate intakes for LA, ALA and DHA as adequate n-6 
and n-3 PUFA requirements to prevent dietary deficit in 
essential fatty acids and to ensure a proper functioning of 
the body. These intakes are 2 and 0.8% EIEA, respectively 
for LA and ALA, and 250 mg/d for DHA.
Results 
Results are presented in Table 1 for the three age 
groups (65-69 y, 70-74 y, and 75-79 y), regardless of 
gender.
French elderly mean total fat intake figures meet the 
RDIs defined by ANSES (10), i.e. 35-40% EIEA: figures 
are 37.8% EIEA (SD 6.2%) for the 65 to 69 years old, 37.3% 
EIEA (SD 6.8%) for the 70 to 74 years old, and 39.3% EIEA 
(SD 6.2%) for the 75 to 79 years old. 
Mean intake of LA (4.2% EIEA) was ranging from 4.1 to 
4.4% EIEA, slightly higher than the ANSES RDI value (4% 
EIEA). This intake increases with age, the 75 to 79 years 
old group having the highest mean intake. About 95% of 
the elderly of the 65-69 and 75-79 years old groups met as 
a minimum LA intake recommendation (i.e. 2% EIEA), 
compared to over 98% for the 70-74 years old elderly.
Average daily intake of ALA was 0.5% EIEA for all age 
groups, half of the RDI value (1% EIEA). Regarding the 
adequate daily intake for this PUFA (0.8% EIEA), from 5% 
to 8.8% of the elderly satisfy this intake, this percentage 
increasing with age. The low intake of ALA associated 
with an intake of LA in accordance with the RDI leads 
to a LA/ALA ratio between 9 and 10, whereas ANSES 
recommendation is inferior to 5.
The average daily intakes of DHA and EPA were 159 
and 118 mg/d, respectively, ranging from 157 (65-69 y) to 
164 (70-74 y) mg/d for DHA (RDI: 250 mg/d), and from 
110 (75-79 y) to 129 (70-74 y) mg/d for EPA (RDI: 250 
mg/d). 
Despite these variations, there was no difference in LA, 
ALA, EPA and DHA dietary intakes based on age.
According to gender (data not shown), elderly men 
have a higher total energy intake than elderly women 
(from 21 to 28.5% higher depending on the age group). 
The mean daily intakes of LA, ALA, and EPA expressed 
in grams per day were higher in men than in women, 
but no differences were observed when expressed as 
a percentage of EIEA. The only recorded significant 
difference concerned the mean daily intake of ALA of 
the 65- to 69-year-old women (0.48 % EIEA, SD 0.18%) 
compared to men of the same group age (0.42 % EIEA, SD 
0.16%).
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Table 1
Mean daily intakes of main polyunsaturated fatty acids of the French elderly population (INCA 2–Ciqual) (Mean 
values and standard deviations; percentages, and 95% confidence intervals)
Mean daily intake INCA 2
% EIEA * g/d, mg/d
ANSES RDIs † and 
adequate intakes ‡
Mean SD Mean SD % meeting § ANSES 
RDIs and adequate 
intakes (95% CI)
65-69 years (n=181 w, 150) ||
Total fat 35%-40% † 37.8 6.2 81.7 g 26.7 38.3 (29.6, 47)
LA (18:2n-6) 4% † 4.1 1.9 9.0 g 5.1 45.7 (36.8, 54.7)
2% ‡ 95.1 (91.3, 99)
ALA (18:3n-3) 1% † 0.5 0.2 1.0 g 0.5 2.3 (-0.4, 5)
0.8% ‡ 5 (1.4, 8.7)
LA/ALA <5 † 9.8 (5.2) 8.1 (3.1, 13.1)
EPA (20:5n-3) 250 mg/d † 0.05 0.05 114 mg 100 6.8 (2.6, 11)
DHA (22:6n-3) 250 mg/d † 0.08 0.06 157 mg 125 21.7 (14.1, 29.3)
EPA+DHA 500 mg/d † 0.13 0.11 271 mg 219 14.2 (7.8, 20.6)
70-74 years (n=135 w, 114) ||
Total fat 35%-40% † 37.3 6.8 79.4 g 25.6 28.5 (18.8, 38.2)
LA (18:2n-6) 4% † 4.2 2.3 8.7 g 4.3 37.7 (27.3, 48)
2% ‡ 98.2 (95.5, 100.9)
ALA (18:3n-3) 1% † 0.5 0.3 1.0 g 0.5 2.5 (0.1, 5)
0.8% ‡ 8 (2.4, 13.5)
LA/ALA <5 † 9.5 (6.5) 5.4 (0.9, 10)
EPA (20:5n-3) 250 mg/d † 0.06 0.07 129 mg 204 11 (4.6, 17.4)
DHA (22:6n-3) 250 mg/d † 0.07 0.08 164 mg 226 17.1 (9.7, 24.5)
EPA+DHA 500 mg/d † 0.13 0.15 293 mg 421 12.5 (5.7, 19.2)
75-79 years (n=103 w, 84) ||
Total fat 35%-40% † 39.3 6.2 78.7 g 22.5 26.3 (16.4, 36.2)
LA (18:2n-6) 4% † 4.4 2.4 8.6 g 4.1 52.3 (40.6, 64)
2% ‡ 94.7 (89.6, 99.8)
ALA (18:3n-3) 1% † 0.5 0.2 1.0 g 0.5 4.9 (-0.4, 10.2)
0.8% ‡ 8.8 (2.2, 15.4)
LA/ALA <5 † 9.9 (6.3) 5.4 (0.5, 10.3)
EPA (20:5n-3) 250 mg/d † 0.06 0.05 110 mg 99 12.2 (4.7, 19.8)
DHA (22:6n-3) 250 mg/d † 0.08 0.07 158 mg 138 18.9 (9.3, 28.4)
EPA+DHA 500 mg/d † 0.14 0.12 267 mg 233 16.8 (7.9, 25.7)
LA, linoleic acid; ALA, alpha-linolenic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; * % EIEA, percentage of total energy intake excluding alcohol; † 
ANSES RDIs, French Agency for Food, Environmental and Occupational Health & Safety (ANSES) recommended dietary intakes (RDIs). ANSES RDIs for adults are 
expressed as % EIEA for LA and ALA (4 and 1% EIEA, respectively), with a recommended LA/ALA ratio lower than 5, and as mg/d for DHA (250 mg/d), EPA+DHA 
(500 mg/d), and EPA (250 mg/d RDI-like figure derived from the DHA and EPA+DHA RDIs); ‡ Adequate intakes of LA and ALA (2 and 0.8% EIEA, respectively) 
to avoid any essential fatty acid dietary deficit-related syndrome and to satisfy n-6 and n-3 PUFA human requirements for the proper functioning of the organism, 
notably development and brain functioning; § Percentage of elderly meeting ANSES RDIs (considered as ≥ 4% for LA, ≥ 1% for ALA, ≥ 250 mg for EPA and DHA and 
≥ 500 mg for EPA+DHA for the calculation of percentages meeting the respective RDIs) or ingesting adequate levels of LA and ALA (considered as ≥ 2% and ≥ 0.8% for 
the calculation of percentages meeting the respective adequate intakes for LA and ALA); || Population size is given as weighted first (w) and raw after. For example, 
there were 150 elderly aged 65-69 in the survey but they are counted as 181 in the statistics presented so that the proportion of elderly at this age is representative of the 
French population.
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Taken together our data show that the overall elderly 
population (over than 95%) for ALA and between 83% 
(75-79 y) and 88% (70-74 y) of the elderly population for 
EPA+DHA do not meet ANSES RDIs for n-3 PUFAs.
Discussion
From this study, it emerges an inadequacy of the n-3 
PUFA intakes of the French elderly population (65-79 
y) with the RDIs. Specifically, besides an adequate total 
fat daily intake and a LA daily intake close or superior 
to the RDI (from 4.1 to 4.4% EIEA vs 4% EIEA), the 
French elderly have, regardless of age and gender, a low 
mean dietary ALA intake equal half of the RDI (0.5% 
EIEA vs 1% EIEA), and a mean dietary DHA intake 
close to two-thirds of the ANSES recommendation (i.e. 
from 154 to 167 mg/d vs 250 mg/d). These translated 
into a LA/ALA ratio between 9.5 and 9.9, twice as 
high as the recommended threshold inferior to 5, and a 
mean dietary EPA+DHA intake (from 267 to 293 mg/d) 
slightly more than half of the RDI (500 mg/d). These 
mean dietary intakes are slightly higher than those 
described for the French adult population (6). The major 
food contributors to PUFA intake in French elderly are 
vegetable oils (25.5%) and condiments and sauces (12.9%) 
for LA, vegetable oils (14.7%) and margarine (11.1%) 
for ALA. Concerning the n-3 long chain PUFAs, the 
main contributor for DHA and EPA was fish (60.1% and 
54.3%, respectively). Although vegetable oils and fish 
are the main dietary sources of ALA, and DHA+EPA, 
respectively, it seems that the inadequacy of the mean 
n-3 PUFA dietary intakes of elderly with the RDIs may be 
due to a not sufficient dietary intake of these foods, even 
if elderly have higher mean intakes for these foods than 
adults (11).
To date, very few studies have focused on PUFA 
intake of the European and French elderly population 
(5). In France, only two studies prior to INCA 2 study 
have reported such data. The first one concerned 1 786 
elderly community dwellers (age range 67.7-94.9 years 
old) from Bordeaux, included in the Three-City cohort, 
in which mean dietary intakes were stratified in age (65-
74 y, 75-84 y, and ≥ 85 y), and gender (4, 12). From data 
collected in 2001/2002, regardless of age and gender, the 
mean dietary intakes of the 1 786 elderly were 3.35% of 
energy intake (EI) (SD 2.35%), and 0.40% EI (SD 0.32%), 
respectively for LA and ALA, leading to a LA/ALA ratio 
of 9.9 (SD 7.05). Concerning n-3 long chain PUFAs, mean 
dietary intakes of EPA and DHA were 140 mg/d (SD 340 
mg/d) and 280 mg/d (SD 690 mg/d), respectively. The 
intake of EPA was below recommended levels by ANSES 
(250 mg/d), while the mean consumption of DHA was 
close to the recommended intake. Gender only affects 
the total fat intake (lower in men than in women when 
expressed in proportion of EI), and no impact on the 
mean dietary intakes of LA, ALA, EPA and DHA. This 
cohort of elderly of southwestern France had higher mean 
EPA and DHA dietary intakes than those observed in the 
INCA 2 study but with very large ranges of intakes due to 
great inter-individual variability. Knowing that the main 
source of EPA and DHA is fish, a food not consumed 
daily in the Three-City cohort, the authors argued that 
these results might probably due to the single 24 h recall 
used which allows a good estimation of the mean but not 
of the variance of the consumption. Besides, compared to 
the present results, the mean dietary intakes of LA and 
ALA were slightly lower, but leading to a similar LA/
ALA ratio. In conclusion, it emerged from this study 
that these elderly have an unbalanced fatty acid intake, 
characterized notably by a deficit of n-3 PUFAs.
The second French study is the CALIPSO survey which 
was conducted in four French coastal regions, in 1 011 
high seafood consumers (fish and seafood at least twice 
weekly) aged 18 years old and over, among which 123 
older subjects (≥ 65 years old) (13). The mean EPA and 
DHA dietary intakes of the 123 older subjects were 467 
mg/d (SD 468 mg/d) and 819 mg/d (SD 737 mg/d), 
respectively, three to four times higher than the mean 
dietary intakes observed in the INCA 2 study. Concerning 
ALA, the mean dietary intakes of elderly (from 43 mg/d 
(SD 27 mg/d) to 95 mg/d (SD 88 mg/d) according to 
the coastal region) covered between 2 to 4.3% of the RDI 
for this PUFA. These values are much lower than those 
observed for the elderly in the INCA 2 study (half of 
the RDI value), due to the fact that the CALIPSO survey 
only studied the fish and seafood consumption and its 
contribution to n-3 long chain PUFA intakes (including 
ALA). Although the comparison with our results is rather 
difficult, these results show however that consumption of 
fish and seafood twice weekly allowed elderly to reach 
the n-3 long chain PUFA RDIs.
In Europe, in addition of the two French studies, nine 
studies from eight other countries have reported intake 
data for elderly aged ≥ 65 years old (for eight of them, 
the last one reporting data in elderly ≥ 60 years old) with 
different levels of accuracy according to the different 
PUFAs (5). From these studies, it emerges that mean 
LA and ALA intakes can be higher (6-7% EI for LA, 
0.6% EI for ALA), lower (2.6% EI for LA, 0.2% EI for 
ALA) or close to that which are observed in the present 
study. Concerning EPA and DHA, a variability has also 
been observed between countries, with a mean dietary 
intake of EPA ranging from 50 to 283 mg/d and a 
mean dietary intake of DHA ranging from 80 to 631 
mg/d. As mentioned by Sioen et al., the heterogeneity 
of the n-3 PUFA dietary intakes between the different 
studies could be due to the different methods used for 
dietary assessments (e.g. 24 h recall, food frequency 
questionnaires, dietary record) which may not capture 
the intake of foods that are not consumed on a daily basis 
such as fish and seafood, hence leading to n-3 PUFA 
intakes incorrectly estimated (5). 
According to notices of AFSSA (former name of 
ANSES), about dietary requirements of elderly people 
suffering from some specific diseases, and WHO, about 
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aging, elderly constitute a heterogeneous population 
in terms of health with altered nutrient requirements. 
These specific requirements are driven by modifications 
in body composition, physical activity, altered nutrient 
intake because of low variety of food consumed, reduced 
appetite, loss of sensory appreciation of food, dentition 
and swallowing problems, the presence of disease and 
social issues. Taken together, these changes may expose 
elderly to a high risk of inadequate PUFA intake, besides 
other important micronutrients (14, 15).
In the elderly, nutrition is one of the major 
determinants of successful aging, defined as the ability 
to maintain low risk of disease and disease-related 
disability, high mental and physical function and 
active engagement of life (16). Knowledge of nutrient 
requirements of older adults is growing yet is still 
inadequately documented. Older adults may have unique 
nutrients needs. The quantity of food and energy intake 
usually decreases substantially across the spectrum of 
aging, as observed in our study. Surprisingly, there is a 
lack of information about fatty acids, mainly n-3 long-
chain PUFAs.
As proof, no recommendations from international and 
European organizations exist for elderly, as no specific 
needs for any of the PUFAs were deemed evident. As 
already mentioned, Japan is the only country to have 
PUFA dietary intake recommendations for elderly (9). 
These RDIs are based on the following considerations that 
for the elderly, weakening of their masticatory function, 
deterioration of digestive and absorptive function, and 
reduction in food intake due to less physical activities 
exist. Characteristics of this age group include frequent 
and wide variation of their individual food intake and 
the fact that many aged individuals are affected by an 
illness. The last update of the RDIs for Japanese elderly 
people, regarding the importance of issues involved with 
under-nutrition, nutritional deficiency as well as over-
nutrition, reviewed scientific data about associations 
between energy or nutrients and frailty or sarcopenia. 
Japan set RDIs for total n-3 PUFA four to five times 
higher that French RDIs with mean dietary intakes 
higher for Japanese men than for women due to studies 
reporting that male older adults are more vulnerable in 
terms of nutrient intake compared with females. This is 
not only to prevent energy or nutrient deficiency that may 
be caused by inadequate nutrient intake, but also for the 
primary prevention of lifestyle-related diseases (9).
In France, the previous update of the French RDIs 
had set specific recommendations for the elderly (> 
75 y) (17). These recommendations were based on in 
vivo data (n-3 PUFA blood status), on the described 
roles of the n-3 PUFAs, and on the fact that n-3 PUFA 
deficiency was associated with skin, ocular, metabolic 
and cognitive disorders, and that the occurrence 
of thrombotic, inflammatory, immune disorders and 
several pathological conditions (osteoporosis, sarcopenia, 
neurodegenerative diseases) increases with age. Taken 
together, and due to the fact that the activity of the 
desaturase enzyme, which converts essential precursors 
in longer-chain PUFAs, might be decreased in ageing, 
these data were in favor of n-3 PUFA RDIs for elderly. 
However, the last update of the French RDIs did not 
maintain specific recommendations for this age group. 
ANSES indeed reassessed the ALA and DHA RDIs for 
adult with increased mean dietary intakes, and, due to 
the lack of specific data for elderly suggesting that dietary 
needs of aged people may be different from adult ones, 
concluded that RDIs for adults also apply to elderly (10).
In conclusion, data collected from the INCA 2 survey 
evidence that 97% of the elderly population do not meet 
the RDIs for ALA versus more than 80% the RDIs for 
EPA+DHA. Detailed data of the third study on the food 
consumption and eating habits of the French population 
(INCA 3) (performed in 2014 and 2015) are expected 
in the next few months and will allow monitoring the 
evolution of PUFA dietary intakes for the different age 
groups of the French elderly population.
Nevertheless, the lack of specific RDIs for elderly 
raises questions about the importance of n-3 PUFAs 
for this age group. More and more scientific data 
reported that optimal nutrition is one of the most 
important determinants of healthier ageing, reducing 
the risk of disability, maintaining mental and physical 
functions, thus preserving and ensuring a better 
quality of life. Among the specific nutrients able to 
play a key role, n-3 PUFAs might have the potential 
of preventing and reducing co-morbidities in older 
adults, including rheumatoid arthritis, depression 
and macular degeneration. More precisely, n-3 PUFA 
status and dietary intake may have beneficial effects on 
cardiovascular system (atherosclerosis, arrhythmias), 
immune function (immune cell proliferation, pro-
inflammatory cytokines, other cellular effects), muscle 
performance (muscle mass and function) and bone 
health in older adults. In addition, given their beneficial 
effects on brain function (dementia, depression and 
cognitive function), n-3 long-chain PUFAs appear to be 
neuroprotective and may also have unique properties in 
affecting neurobiology, both of critical interest during 
the aging process. Indeed, in contrast to their proposed 
actions in childhood, where they are required for healthy 
development of brain tissue, in older age n-3 PUFAs are 
more like to act in a protective and health maintaining 
manner (16, 18, 19).
N-3 PUFAs are so now identified as potential key 
nutrients, safe and effective in the treatment and 
prevention of several negative consequences of ageing. 
The available data encourage higher intakes of n-3 
PUFAs, and recommendations for intake of these fatty 
acids should be developed for the elderly population.
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